By Commerce Reporter
LAHORE, November 6: First National Equities Limited (FNEL) has announced its strategic entry into the pharmaceutical and healthcare sector, marking another major diversification move after its foray into property technology.
Read also:First National Equities Limited concludes Annual General Meeting 2025
According to a disclosure submitted to the Pakistan Stock Exchange (PSX), the company’s Board of Directors, in an emergent meeting, granted in-principle approval for the proposed acquisition of a 100% equity stake in Albert Pharma (Private) Limited. The acquisition is subject to due diligence, definitive agreements, and fulfillment of regulatory requirements.
FNEL stated that this initiative aligns with its long-term strategic vision to gradually expand beyond stock brokerage and explore new growth sectors, including pharmaceuticals, healthcare, and allied industries. The Board has also instructed the CEO and Company Secretary to prepare a comprehensive Shariah-compliant business and financial plan in accordance with SECP and PSX rules.
The company emphasized that its fundamentals are evolving as it transitions into a multi-sector enterprise, focusing on sustainable financial stability and long-term value creation for shareholders.
Market analysts view this diversification as a positive signal, expecting FNEL’s expansion into the high-growth pharma sector to strengthen its financial base and offer fresh opportunities for investors.
